Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-19

Clinical Trial Update: A Drug-drug Interaction Study With Risdiplam Multiple Dose and Midazolam in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 study evaluating drug-drug interaction between risdiplam (multiple dose) and midazolam in healthy participants with spinal muscular atrophy; completed r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Midazolam (Midazolam)
  • Risdiplam (risdiplam)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Spinal Muscular Atrophy | Phase 1 | Status: COMPLETED | Results posted: 2020-10-19